Levetiracetam
Treatment for Idiopathic epilepsy
Typical Dosage: 500-3000 mg daily
Effectiveness
80%
Safety Score
60%
Clinical Trials
4
Participants
60K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
500-3000 mg daily
Time to Effect
Days to weeks
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,000
Monitoring:$500
Side Effect Mgmt:$300
Total Annual:$1,800
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$15,000/QALY
QALYs Gained
6
Outcome-Based Costs
Cost per Responder
$3,600
Cost per Remission
$5,143
Levetiracetam Outcomes
for Idiopathic epilepsy
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+50%
Remission Rate
+35%
Common Side Effects
Somnolence/Fatigue
+18%
Irritability/Agitation
+15%
Dizziness
+12%
Headache
+10%
Anorexia
+8%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
4 completed trials for Levetiracetam in Idiopathic epilepsy
Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures
NCT03940326COMPLETEDPHASE4
103 participants
INTERVENTIONAL
Sari, Iran
Started: Apr 1, 2018
Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy
NCT06393309COMPLETED
169 participants
OBSERVATIONAL
Sari, Iran
Started: Sep 3, 2022
Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures
NCT00160550COMPLETEDPHASE3
154 participants
INTERVENTIONAL
Started: Sep 1, 2001
Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
NCT00150774COMPLETEDPHASE3
116 participants
INTERVENTIONAL
Started: Nov 1, 2001